The HGSA COSA Cancer Genetics special interest group (SIG) aims to provide cross disciplinary representation for members of the HGSA and COSA that work in all aspects Cancer Genetics. As part of our commitment to our members we will deliver regular webinars on topics relevant to those working in familial and somatic cancer genetics.
Our upcoming webinar is on Thursday the 30th March, 2023 (2pm AEDT).
Topic: Hereditary Diffuse Gastric Cancer
Speakers:
Parry Guilford: Hereditary Diffuse Gastric Cancer: recurrent concerns, evolving issues and the path to chemoprevention
Parry Guilford is a Professor of Cancer Genetics at the University of Otago. His research areas include the genetics and management of inherited cancers, in particular Hereditary Diffuse Gastric Cancer (HDGC). Most recently, this has focused on the identification of synthetic lethal vulnerabilities which can be exploited for the chemoprevention of HDGC. Other active research areas include the development and implementation of genomics-based cancer diagnostic tools, and the use of these technologies to reduce inequities in healthcare.
Massimiliano Di Pietro: The role of endoscopic surveillance in the management of Hereditary Diffuse Gastric Cancer
Massimiliano di Pietro qualified from Federico II University of Naples, Italy and obtained an MD at the Institute of Molecular Cancer Research (University of Zurich, Switzerland). He is Senior Clinical Investigator Scientist at the Early Cancer Institute, University of Cambridge and Honorary Consultant Gastroenterologist at Addenbrooke’s Hospital, where he provides regional referral for endoscopic treatment of pre-cancerous and early malignant conditions of the upper GI tract, including endoscopic mucosal resection, endoscopic submucosal dissection and Radiofrequency Ablation. Dr di Pietro has a research interest in oesophageal and gastric pathologies, including Barrett’s oesophagus, oesophageal cancer and hereditary gastric cancer. In particular, his scientific focus is in advanced endoscopic imaging, endoscopic therapies and molecular biomarkers for cancer risk stratification. He has co-authored the current British and European guidelines for management of Barrett’s oesophagus and the International Guidelines for the management of Hereditary Diffuse Gastric Cancer. He is lead on several prospective endoscopy trials for the early detection of upper GI cancer.
Karyn Paringatai: Family histories, knowledges, and experiences
Karyn Paringatai (Ngati Porou) is an Associate Professor in Te Tumu – School of Maori, Pacific & Indigenous Studies at the University of Otago where she has been teaching for over 20 years primarily in the areas of te reo Maori (Maori language), Maori performing arts and Maori cultural knowledge. Her research expertise is in the broad field of Maori Studies, and is interdisciplinary focusing specifically on: Maori teaching methodologies; sociological issues surrounding Maori urbanisation and Maori identity development and maintenance; Maori performing arts; and Maori health.
The Cancer Genetics SIG would like to encourage anyone working in or with a special interest in somatic and/or cancer genetics to become a member. By being a member of the Cancer Genetics SIG you will have access to educational activities, have input into policies and guidelines, and be part of a growing community of those working in cancer genetics. If you would like to join the Cancer Genetics SIG Executive, we encourage you to contact us through the HGSA Secretariat.